Pricing Log in Create free account

Perspective Therapeutics, Inc. (CATX) vs TriSalus Life Sciences, Inc. (TLSI)

Perspective Therapeutics, Inc. and TriSalus Life Sciences, Inc. are both Medical Devices companies. Perspective Therapeutics, Inc. is the larger, with a market value of $267.1M against $240.1M — 1.1× the size. TriSalus Life Sciences, Inc. grew revenue faster over the last twelve months: 25.3% against −66.9%. TriSalus Life Sciences, Inc. has the higher net margin (−127.0% vs −28,468.0%) and the higher return on invested capital (0.00% vs −88.4%). Across the 17 metrics below, TriSalus Life Sciences, Inc. leads on 11 and Perspective Therapeutics, Inc. on 6.

Valuation

Metric CATX TLSI Medical Devices median
P/E n/m n/m 23.22
P/S 640.13 4.69 2.34
P/B 0.81 32.31 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 64.74 4.41 2.24
Earnings yield (61.15%) (35.81%) (10.09%)
Free cash flow yield (46.29%) (11.33%) (8.47%)

Profitability

Metric CATX TLSI Medical Devices median
Gross margin 100.00% 85.79% 56.01%
Operating margin (30,619.07%) (67.68%) (15.03%)
Net margin (28,467.97%) (127.00%) (20.40%)
Free cash flow margin (29,630.07%) (51.56%) (7.24%)
Return on equity (39.50%) 889.44% (15.32%)
Return on assets (33.14%) (110.34%) (19.72%)
Return on invested capital (88.41%) 0.00% (10.33%)

Growth

Metric CATX TLSI Medical Devices median
Revenue growth (TTM) (66.88%) 25.25% 8.80%
EPS growth (last fiscal year) (13.82%) (40.46%) 29.03%
Revenue growth, 5-year CAGR (38.04%) — 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CATX TLSI Medical Devices median
Debt to equity 0.00 5.05 0.07
Current ratio 6.61 5.35 2.50
Net debt to EBITDA 1.27 (0.50) 0.49

Dividend

Metric CATX TLSI Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric CATX TLSI Medical Devices median
Market cap 267.12m 240.14m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack